Modeling familial British and Danish dementia
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Familial British dementia (FBD) and familial Danish dementia (FDD) are two autosomal dominant neurodegenerative diseases caused by mutations in the BRI2 gene. FBD and FDD are characterized by widespread cerebral amyloid angiopathy (CAA), parenchymal amyloid deposition, and neurofibrillary tangles. Transgenic mice expressing wild-type and mutant forms of the BRI2 protein, Bri2 knock-in mutant mice, and Bri2 gene knock-out mice have been developed. Transgenic mice expressing a human FDD-mutated form of the BRI2 gene have partially reproduced the neuropathological lesions observed in FDD. These mice develop extensive CAA, parenchymal amyloid deposition, and neuroinflammation in the central nervous system. These animal models allow the study of the molecular mechanism(s) underlying the neuronal dysfunction in these diseases and allow the development of potential therapeutic approaches for these and related neurodegenerative conditions. In this review, a comprehensive account of the advances in the development of animal models for FBD and FDD and of their relevance to the study of Alzheimer disease is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938 · cited 2×
“2009), which may play an important role in the pathogenesis of FDD since in AD it has been suggested that oligomers and protofibrils rather than fibrillar structures are responsible for the pathogenesis of the disease (Walsh and Selkoe 2007).”
Control of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550 · cited 2×
“(2008) generated transgenic mice expressing human wild-type BRI2 under the control of the calcium– calmodulin-dependent kinase II (aCaMKII) promoter (Mayford et al. 1996), which drives the expression of the transgene in the postnatal forebrain.”
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 637 · cited 3×
“When mice expressing BRI2–Ab42 were crossed with mutant AbPP (Tg2576) transgenic mice, there was also a massive increase in amyloid deposition, establishing that Ab42 is essential for amyloid deposition in the parenchyma and also in vessels (McGowan et al. 2005).”
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466 · cited 9×
“BRI2 and generation of amyloid peptides The characterization of amyloid fibrils isolated from FBD and FDD individuals (Vidal et al. 1999, 2000b) led to the cloning of the BRI2 gene (also known as ITM2b, Deleersnijder et al. 1996) and the identification of the genetic defects associated with these…”
InfluentialSelf-citationAβ40 Inhibits Amyloid Deposition In Vivo
Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D. W., Golde, T., & McGowan, E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4849-06.2007 · Cited by 415
Vidal, R., Révész, T., Rostagno, A., Kim, E., Holton, J. L., Bek, T., Bojsen-Møller, M., Braendgaard, H., Plant, G., Ghiso, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080076097 · Cited by 300
Self-citationAlzheimer disease therapy: Can the amyloid cascade be halted?
Golde, T. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17527 · Cited by 164 · cited 2×
“This finding of similar pathological lesions seems to support a unifying pathologic mechanism in which accumulation of amyloidogenic peptides could trigger a complex pathological cascade leading to neurodegeneration (Golde 2003).”
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
Kim, S.-H., Wang, R., Gordon, D. J., Bass, J., Steiner, D. F., Lynn, D. G., Thinakaran, G., Meredith, S. C., & Sisodia, S. S. (1999) · Nature Neuroscience · doi:10.1038/14783 · Cited by 154 · cited 3×
“Cleavage between residues Arg243 and Glu244 by PCs (Kim et al. 1999, 2002; Choi et al. 2004) releases the 34 amino acid ABri and ADan peptides from the 277 amino acid mutant forms of BRI2 associated with FBD and FDD (Fig.”
Matsuda, S., Giliberto, L., Matsuda, Y., Davies, P., McGowan, E., Pickford, F., Ghiso, J., Frangione, B., & D'Adamio, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500217200 · Cited by 141
Self-citationBRI2 (ITM2b) Inhibits A Deposition In Vivo
Kim, J., Miller, V. M., Levites, Y., West, K. J., Zwizinski, C. W., Moore, B. D., Troendle, F. J., Bann, M., Verbeeck, C., Price, R. W., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0891-08.2008 · Cited by 120 · cited 3×
“V717F AbPP mice (Kim et al. 2008).”
BRI2 Interacts with Amyloid Precursor Protein (APP) and Regulates Amyloid β (Aβ) Production
Fotinopoulou, A., Tsachaki, M., Vlavaki, M., Poulopoulos, A., Rostagno, A., Frangione, B., Ghiso, J., & Efthimiopoulos, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500231200 · Cited by 114 · cited 3×
“Although the function of BRI2 remains largely unknown, it has been found to interact with AbPP, the precursor of Ab, decreasing the efficiency of AbPP processing to generate Ab (Fotinopoulou et al. 2005; Matsuda et al. 2005, 2008).”
Tomidokoro, Y., Lashley, T., Rostagno, A., Neubert, T. A., Bojsen-Møller, M., Braendgaard, H., Plant, G., Holton, J., Frangione, B., Révész, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504038200 · Cited by 68 · cited 1×
“Ab deposition, mostly Ab42, was observed either in combination with ADan or alone in blood vessel walls and in brain parenchyma (Holton et al. 2002; Tomidokoro et al. 2005).”
Lawlor, P. A., Bland, R. J., Das, P., Price, R. W., Holloway, V., Smithson, L., Dicker, B. L., During, M. J., Young, D., & Golde, T. E. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-11 · Cited by 67 · cited 1×
“The system was used to generate AAV vectors to target expression of individual Ab peptides to the hippocampus of adult rats, allowing the examination of the role of each peptide in the pathology and cognitive deficits seen in AD models in the absence of AbPP over-expression (Lawlor et al. 2007).”
Proteolytic Processing of Familial British Dementia-associated BRI Variants
Kim, S.-H., Creemers, J. W. M., Chu, S., Thinakaran, G., & Sisodia, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108739200 · Cited by 63
Vidal, R., Barbeito, A. G., Miravalle, L., & Ghetti, B. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00164.x · Cited by 60 · cited 11×
“Immunohistochemistry using Ab 1700 was done as described ( Vidal et al. 2009 )( b). Scale bars a, b 200 lm Brain Struct Funct (2010) 214:235‐244 239”
InfluentialSelf-citation
Cited by
Del Prete, D., Rice, R. C., Rajadhyaksha, A. M., & D'Adamio, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733626 · Cited by 86
Self-citationTambini, M. D., Yao, W., & D'Adamio, L. (2019) · Aging Cell · doi:10.1111/acel.13033 · Cited by 40
Self-citationTau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy
You, Y., Perkins, A., Cisternas, P., Muñoz, B., Taylor, X., You, Y., Garringer, H. J., Oblak, A. L., Atwood, B. K., Vidal, R., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0680-z · Cited by 33
“Since BRI2 is a transmembrane protein and the Danish mutation induced the secretion of the ADan peptide to the extracellular space [22] (Additional file 1: Figure S2),”
Self-citationFunctional BRI2-TREM2 interactions in microglia: implications for Alzheimer’s and related dementias
Yin, T., Yesiltepe, M., & D’Adamio, L. (2024) · EMBO Reports · doi:10.1038/s44319-024-00077-x · Cited by 15
Self-citationYin, T., Yao, W., Norris, K. A., & D’Adamio, L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101089 · Cited by 14
Self-citation
Metadata
- Authors
- Garringer, H. J., Murrell, J., D’Adamio, L., Ghetti, B., & Vidal, R.
- Venue
- Brain Structure and Function
- Published
- 2009-09-25
- Volume
- 214
- Issue
- 2-3
- Pages
- 235-244
- ISSN
- 1863-2653 (ISSN-L)
- 1863-2661
- OpenAlex
- W2091499229
- Cited by
- 48
- References
- 15
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.